577 related articles for article (PubMed ID: 19136966)
1. Nuclear signalling by tumour-associated antigen EpCAM.
Maetzel D; Denzel S; Mack B; Canis M; Went P; Benk M; Kieu C; Papior P; Baeuerle PA; Munz M; Gires O
Nat Cell Biol; 2009 Feb; 11(2):162-71. PubMed ID: 19136966
[TBL] [Abstract][Full Text] [Related]
2. Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis.
Warneke VS; Behrens HM; Haag J; Krüger S; Simon E; Mathiak M; Ebert MP; Röcken C
Br J Cancer; 2013 Oct; 109(8):2217-27. PubMed ID: 24008668
[TBL] [Abstract][Full Text] [Related]
3. The role of nuclear EpICD in extrahepatic cholangiocarcinoma: association with β-catenin.
Jachin S; Bae JS; Sung JJ; Park HS; Jang KY; Chung MJ; Kim DG; Moon WS
Int J Oncol; 2014 Aug; 45(2):691-8. PubMed ID: 24888903
[TBL] [Abstract][Full Text] [Related]
4. Initial activation of EpCAM cleavage via cell-to-cell contact.
Denzel S; Maetzel D; Mack B; Eggert C; Bärr G; Gires O
BMC Cancer; 2009 Nov; 9():402. PubMed ID: 19925656
[TBL] [Abstract][Full Text] [Related]
5. Nuclear EpICD expression and its role in hepatocellular carcinoma.
Park SY; Bae JS; Cha EJ; Chu HH; Sohn JS; Moon WS
Oncol Rep; 2016 Jul; 36(1):197-204. PubMed ID: 27176150
[TBL] [Abstract][Full Text] [Related]
6. Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells.
Liang KH; Tso HC; Hung SH; Kuan II; Lai JK; Ke FY; Chuang YT; Liu IJ; Wang YP; Chen RH; Wu HC
Cancer Lett; 2018 Oct; 433():165-175. PubMed ID: 29981429
[TBL] [Abstract][Full Text] [Related]
7. Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition.
Brown TC; Sankpal NV; Gillanders WE
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209658
[TBL] [Abstract][Full Text] [Related]
8. [EpCAM a proteolytically cleaved oncogene and an excellent therapeutic target in cancer].
Gires O
Med Sci (Paris); 2009 May; 25(5):449-50. PubMed ID: 19480822
[No Abstract] [Full Text] [Related]
9. Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer.
Fong D; Moser P; Kasal A; Seeber A; Gastl G; Martowicz A; Wurm M; Mian C; Obrist P; Mazzoleni G; Spizzo G
Histopathology; 2014 Apr; 64(5):683-92. PubMed ID: 24117877
[TBL] [Abstract][Full Text] [Related]
10. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
11. MMP7 is a target of the tumour-associated antigen EpCAM.
Denzel S; Mack B; Eggert C; Massoner P; Stöcklein N; Kemming D; Harréus U; Gires O
Int J Exp Pathol; 2012 Oct; 93(5):341-53. PubMed ID: 22974215
[TBL] [Abstract][Full Text] [Related]
12. Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas.
Fong D; Seeber A; Terracciano L; Kasal A; Mazzoleni G; Lehne F; Gastl G; Spizzo G
J Clin Pathol; 2014 May; 67(5):408-14. PubMed ID: 24465008
[TBL] [Abstract][Full Text] [Related]
13. Epithelial cell adhesion molecule regulates tumor initiation and tumorigenesis via activating reprogramming factors and epithelial-mesenchymal transition gene expression in colon cancer.
Lin CW; Liao MY; Lin WW; Wang YP; Lu TY; Wu HC
J Biol Chem; 2012 Nov; 287(47):39449-59. PubMed ID: 22989882
[TBL] [Abstract][Full Text] [Related]
14. Regulated intramembrane proteolysis and degradation of murine epithelial cell adhesion molecule mEpCAM.
Hachmeister M; Bobowski KD; Hogl S; Dislich B; Fukumori A; Eggert C; Mack B; Kremling H; Sarrach S; Coscia F; Zimmermann W; Steiner H; Lichtenthaler SF; Gires O
PLoS One; 2013; 8(8):e71836. PubMed ID: 24009667
[TBL] [Abstract][Full Text] [Related]
15. Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming.
Huang HP; Chen PH; Yu CY; Chuang CY; Stone L; Hsiao WC; Li CL; Tsai SC; Chen KY; Chen HF; Ho HN; Kuo HC
J Biol Chem; 2011 Sep; 286(38):33520-32. PubMed ID: 21799003
[TBL] [Abstract][Full Text] [Related]
16. A novel therapeutic drug for colon cancer: EpCAM scFv-truncated protamine (tp)-siRNA.
Hao H; Zhen Y; Wang Z; Chen F; Xie X
Cell Biol Int; 2013 Aug; 37(8):860-4. PubMed ID: 23576466
[TBL] [Abstract][Full Text] [Related]
17. Transcription factors and molecular epigenetic marks underlying EpCAM overexpression in ovarian cancer.
van der Gun BT; de Groote ML; Kazemier HG; Arendzen AJ; Terpstra P; Ruiters MH; McLaughlin PM; Rots MG
Br J Cancer; 2011 Jul; 105(2):312-9. PubMed ID: 21694727
[TBL] [Abstract][Full Text] [Related]
18. EpCAM regulates cell cycle progression via control of cyclin D1 expression.
Chaves-Pérez A; Mack B; Maetzel D; Kremling H; Eggert C; Harréus U; Gires O
Oncogene; 2013 Jan; 32(5):641-50. PubMed ID: 22391566
[TBL] [Abstract][Full Text] [Related]
19. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation.
Münz M; Kieu C; Mack B; Schmitt B; Zeidler R; Gires O
Oncogene; 2004 Jul; 23(34):5748-58. PubMed ID: 15195135
[TBL] [Abstract][Full Text] [Related]
20. EpCAM proteolysis: new fragments with distinct functions?
Schnell U; Kuipers J; Giepmans BN
Biosci Rep; 2013 Mar; 33(2):e00030. PubMed ID: 23409978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
